会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • MODIFIED AND STABILIZED GDF PROPEPTIDES AND USES THEREOF
    • 修改和稳定的GDF预测及其用途
    • US20070238683A1
    • 2007-10-11
    • US11614594
    • 2006-12-21
    • Neil WolfmanSoo-Peang KhorKathleen Tomkinson
    • Neil WolfmanSoo-Peang KhorKathleen Tomkinson
    • A61K31/7052C07H21/04C12N15/00C12N5/06
    • C07K14/475C07K14/51C07K16/18C07K2319/00
    • Modified and stabilized propeptides of Growth Differentiation Factor proteins, such as GDF-8 and Bone Morphogenetic Protein-11, are disclosed. Also disclosed are methods for making and using the modified propeptides to prevent or treat human or animal disorders in which an increase in muscle tissue would be therapeutically beneficial. Such disorders include muscle or neuromuscular disorders (such as amyotrophic lateral sclerosis, muscular dystrophy, muscle atrophy, congestive obstructive pulmonary disease, muscle wasting syndrome, sarcopenia, or cachexia), metabolic diseases or disorders (such as such as type 2 diabetes, noninsulin-dependent diabetes mellitus, hyperglycemia, or obesity), adipose tissue disorders (such as obesity), and bone degenerative diseases (such as osteoporosis).
    • 公开了生长分化因子蛋白如GDF-8和骨形态发生蛋白-11的修饰和稳定的前肽。 还公开了制备和使用经修饰的前肽以预防或治疗其中肌肉组织增加在治疗上有益的人或动物疾病的方法。 这些疾病包括肌肉或神经肌肉疾病(例如肌萎缩性侧索硬化症,肌营养不良症,肌肉萎缩,充血性阻塞性肺病,肌肉萎缩综合症,肌营养不良或恶病质),代谢疾病或病症(如2型糖尿病,非胰岛素依赖性糖尿病 高血糖或肥胖),脂肪组织障碍(如肥胖症)和骨退行性疾病(如骨质疏松症)。
    • 2. 发明申请
    • MODIFIED AND STABILIZED GDF PROPEPTIDES AND USES THEREOF
    • 修改和稳定的GDF预测及其用途
    • US20070149455A1
    • 2007-06-28
    • US11614702
    • 2006-12-21
    • Neil WolfmanSoo-Peang KhorKathleen Tomkinson
    • Neil WolfmanSoo-Peang KhorKathleen Tomkinson
    • A61K38/18C07K14/475
    • C07K14/475C07K14/51C07K16/18C07K2319/00
    • Modified and stabilized propeptides of Growth Differentiation Factor proteins, such as GDF-8 and Bone Morphogenetic Protein-11, are disclosed. Also disclosed are methods for making and using the modified propeptides to prevent or treat human or animal disorders in which an increase in muscle tissue would be therapeutically beneficial. Such disorders include muscle or neuromuscular disorders (such as amyotrophic lateral sclerosis, muscular dystrophy, muscle atrophy, congestive obstructive pulmonary disease, muscle wasting syndrome, sarcopenia, or cachexia), metabolic diseases or disorders (such as such as type 2 diabetes, noninsulin-dependent diabetes mellitus, hyperglycemia, or obesity), adipose tissue disorders (such as obesity), and bone degenerative diseases (such as osteoporosis).
    • 公开了生长分化因子蛋白如GDF-8和骨形态发生蛋白-11的修饰和稳定的前肽。 还公开了制备和使用经修饰的前肽以预防或治疗其中肌肉组织增加在治疗上有益的人或动物疾病的方法。 这些疾病包括肌肉或神经肌肉疾病(如肌萎缩性侧索硬化,肌营养不良,肌肉萎缩,充血性阻塞性肺疾病,肌肉萎缩综合征,肌营养不良或恶病质),代谢疾病或病症(例如2型糖尿病, 依赖性糖尿病,高血糖或肥胖),脂肪组织障碍(如肥胖症)和骨退行性疾病(如骨质疏松症)。